A Senate Committee has passed a bipartisan FDA reauthorization bill that includes several provisions aimed at improving drug safety, bringing breakthrough treatments to patients more quickly, advancing medical device innovations and preventing critical drug shortages.
Read the full report in Becker’s Hospital Review on the FDA reauthorization bill.
